PLRX - Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook
2025-10-10 09:03:44 ET
More on Allogene Therapeutics, Pliant Therapeutics
- Allogene Therapeutics, Inc. (ALLO) Presents at Citi's SMID Call Series 2025 Transcript
- Allogene Therapeutics: Important Catalysts Guided For Early 2026
- Allogene Therapeutics, Inc. (ALLO) Q2 2025 Earnings Call Transcript
- Allogene outlines clinical milestones with MRD data readout planned for first half 2026 as portfolio advances
- Allogene Therapeutics GAAP EPS of -$0.23 beats by $0.05